246 related articles for article (PubMed ID: 37333985)
1. A novel glycolysis-related gene signature for predicting the prognosis of multiple myeloma.
Zhang B; Wang Q; Lin Z; Zheng Z; Zhou S; Zhang T; Zheng D; Chen Z; Zheng S; Zhang Y; Lin X; Dong R; Chen J; Qian H; Hu X; Zhuang Y; Zhang Q; Jin Z; Jiang S; Ma Y
Front Cell Dev Biol; 2023; 11():1198949. PubMed ID: 37333985
[No Abstract] [Full Text] [Related]
2. A Comprehensive Prognostic and Immunological Analysis of a Six-Gene Signature Associated With Glycolysis and Immune Response in Uveal Melanoma.
Liu J; Lu J; Li W
Front Immunol; 2021; 12():738068. PubMed ID: 34630418
[TBL] [Abstract][Full Text] [Related]
3. Identification of a glycolysis- and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma.
Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Peng J; Xie Y
Front Cell Dev Biol; 2022; 10():971992. PubMed ID: 36081904
[No Abstract] [Full Text] [Related]
4. Identification of Prognostic Glycolysis-Related lncRNA Signature in Tumor Immune Microenvironment of Hepatocellular Carcinoma.
Bai Y; Lin H; Chen J; Wu Y; Yu S
Front Mol Biosci; 2021; 8():645084. PubMed ID: 33968985
[No Abstract] [Full Text] [Related]
5. Comprehensive Analysis of the Glycolysis-Related Gene Prognostic Signature and Immune Infiltration in Endometrial Cancer.
Yang X; Li X; Cheng Y; Zhou J; Shen B; Zhao L; Wang J
Front Cell Dev Biol; 2021; 9():797826. PubMed ID: 35223866
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of a GRGPI model for predicting the prognostic and treatment outcomes in head and neck squamous cell carcinoma.
Han F; Wang HZ; Chang MJ; Hu YT; Liang LZ; Li S; Liu F; He PF; Yang XT; Li F
Front Oncol; 2022; 12():972215. PubMed ID: 36713509
[TBL] [Abstract][Full Text] [Related]
7. Identification and Validation of a Novel Glycolysis-Related Gene Signature for Predicting the Prognosis and Therapeutic Response in Triple-Negative Breast Cancer.
Zheng J; Zhang YF; Han GH; Fan MY; Du MH; Zhang GC; Zhang B; Qiao J; Zhang SX; Cao JM
Adv Ther; 2023 Jan; 40(1):310-330. PubMed ID: 36316558
[TBL] [Abstract][Full Text] [Related]
8. A combined hypoxia and immune gene signature for predicting survival and risk stratification in triple-negative breast cancer.
Yang X; Weng X; Yang Y; Zhang M; Xiu Y; Peng W; Liao X; Xu M; Sun Y; Liu X
Aging (Albany NY); 2021 Aug; 13(15):19486-19509. PubMed ID: 34341184
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive Characterization of RNA Processing Factors in Gastric Cancer Identifies a Prognostic Signature for Predicting Clinical Outcomes and Therapeutic Responses.
Lou S; Meng F; Yin X; Zhang Y; Han B; Xue Y
Front Immunol; 2021; 12():719628. PubMed ID: 34413861
[TBL] [Abstract][Full Text] [Related]
10. A Prognostic Model of Differentiated Thyroid Cancer Based on Up-Regulated Glycolysis-Related Genes.
Wu M; Ou-Yang DJ; Wei B; Chen P; Shi QM; Tan HL; Huang BQ; Liu M; Qin ZE; Li N; Hu HY; Huang P; Chang S
Front Endocrinol (Lausanne); 2022; 13():775278. PubMed ID: 35528004
[TBL] [Abstract][Full Text] [Related]
11. A Novel Glycolysis-Related Long Noncoding RNA Signature for Predicting Overall Survival in Gastric Cancer.
Zeng J; Li M; Dai K; Zuo B; Guo J; Zang L
Pathol Oncol Res; 2022; 28():1610643. PubMed ID: 36419649
[No Abstract] [Full Text] [Related]
12. A novel prognostic signature based on four glycolysis-related genes predicts survival and clinical risk of hepatocellular carcinoma.
Chen Z; Zou Y; Zhang Y; Chen Z; Wu F; Shi N; Jin H
J Clin Lab Anal; 2021 Nov; 35(11):e24005. PubMed ID: 34523732
[TBL] [Abstract][Full Text] [Related]
13. Identification and verification of a glycolysis-related gene signature for gastric cancer.
Liu Y; Wu M; Cao J; Zhu Y; Ma Y; Pu Y; Huo X; Wang J
Ann Transl Med; 2022 Sep; 10(18):1010. PubMed ID: 36267782
[TBL] [Abstract][Full Text] [Related]
14. Effects of Glycolysis-Related Genes on Prognosis and the Tumor Microenvironment of Hepatocellular Carcinoma.
Zheng JY; Liu JY; Zhu T; Liu C; Gao Y; Dai WT; Zhuo W; Mao XY; He BM; Liu ZQ
Front Pharmacol; 2022; 13():895608. PubMed ID: 35924040
[No Abstract] [Full Text] [Related]
15. A Novel Prognostic Signature Based on Metabolism-Related Genes to Predict Survival and Guide Personalized Treatment for Head and Neck Squamous Carcinoma.
Li Y; Weng Y; Pan Y; Huang Z; Chen X; Hong W; Lin T; Wang L; Liu W; Qiu S
Front Oncol; 2021; 11():685026. PubMed ID: 34195087
[TBL] [Abstract][Full Text] [Related]
16. Identification and validation of a novel cuproptosis-related gene signature in multiple myeloma.
Zhang B; Wang Q; Zhang T; Zheng Z; Lin Z; Zhou S; Zheng D; Chen Z; Zheng S; Zhang Y; Lin X; Dong R; Chen J; Qian H; Hu X; Zhuang Y; Zhang Q; Jin Z; Jiang S; Ma Y
Front Cell Dev Biol; 2023; 11():1159355. PubMed ID: 37152283
[No Abstract] [Full Text] [Related]
17. Integrative transcriptional characterization of cell cycle checkpoint genes promotes clinical management and precision medicine in bladder carcinoma.
Shi WW; Guan JZ; Long YP; Song Q; Xiong Q; Qin BY; Ma ZQ; Hu Y; Yang B
Front Oncol; 2022; 12():915662. PubMed ID: 36033441
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive
Xu T; Xu W; Zheng Y; Li X; Cai H; Xu Z; Zou Q; Yu B
Front Immunol; 2022; 13():931906. PubMed ID: 35958598
[TBL] [Abstract][Full Text] [Related]
19. Transcriptome analysis reveals the prognostic and immune infiltration characteristics of glycolysis and hypoxia in head and neck squamous cell carcinoma.
Liu J; Lu J; Li W
BMC Cancer; 2022 Mar; 22(1):352. PubMed ID: 35361159
[TBL] [Abstract][Full Text] [Related]
20. A Glycolysis-Related Gene Signature Correlates With the Characteristics of the Tumor Immune Microenvironment and Predicts Prognosis in Patients With Hepatocellular Carcinoma.
Yang J; Zhang Y; Duan J; Huang X; Yu H; Hu Z
Front Mol Biosci; 2022; 9():834976. PubMed ID: 35573744
[No Abstract] [Full Text] [Related]
[Next] [New Search]
